Our results come from the largest multicenter, placebo-control randomized trial of succimer (or any chelating agent) so far, and show that succimer has no effect on blood cadmium (BCd) after one week, the time point at which succimer shows maximum efficacy for reducing blood lead. 
Background
• Cadmium: renal toxicity, hypertension, skeletal disorders • Early-life low-level exposure: lower IQ • No known drug to reduce body stores of cadmium in children
Objective
To examine the effect of succimer in reducing blood cadmium concentrations
Methods
• 780 children were randomized to succimer and placebo group • Inductively coupled plasma mass spectrometry • Linear quantile regression model 
